首页> 外文期刊>Journal of clinical laboratory analysis. >Application of multiplex methylated‐specific PCR PCR with capillary electrophoresis to explore prognostic value of TSG TSG s hypermethylation for hepatocellular carcinoma
【24h】

Application of multiplex methylated‐specific PCR PCR with capillary electrophoresis to explore prognostic value of TSG TSG s hypermethylation for hepatocellular carcinoma

机译:多重甲基化特异性PCR PCR与毛细管电泳的应用探讨Tsg Tsg S高甲基化肝细胞癌的预后值

获取原文
获取原文并翻译 | 示例
           

摘要

Background Hepatocellular carcinoma ( HCC ) is a malignant tumor that severely threatens human health. To date, early detection for HCC patients is particularly significant due to their poor survival rates even after liver resection. Methods Therefore, an efficient and sensitive detection method for monitoring liver cancer, multiplex methylation‐specific PCR ( MSP ) coupled with capillary electrophoresis, is developed. Results Simulations demonstrated that the methylation status of RASSF 1A , p16 , SFRP 1 , and ELF could be detected even when DNA equaled or exceeded 12.5?ng simultaneously. Also, its accuracy for methylation detection outweighed polyacrylamide gel electrophoresis (87.5%) and agarose electrophoresis (84.3%), reaching 92.1%. Subsequently, we implemented multiplex MSP with capillary electrophoresis to investigate methylation status of the four tumor suppressor genes in tissue specimens and explore the prognostic value for HCC patients. As the data suggested, multivariate cox regression analysis revealed that the recurrence‐free survival of 46 patients was greatly associated with portal vein tumor thrombus ( PVTT ) and p16 methylation and receiver operating characteristic ( ROC ) curves demonstrated that the predictive range of portal vein tumor thrombus ( PVTT ) combined with p16 hypermethylation was more sensitive than that of either PVTT or p16 hypermethylation alone with regard to disease recurrence in patients with HCC , which could be testified as a valuable biomarker in Clinical application. Conclusion Multiplex MSP coupled with capillary electrophoresis has an excellent prospect of clinical application for monitoring early liver cancer and screening valuable biomarkers for prognosis of HCC patients.
机译:背景技术肝细胞癌(HCC)是一种恶性肿瘤,严重威胁人类健康。迄今为止,由于肝切除术后,HCC患者的早期检测是由于其存活率差。因此,制定了用于监测肝癌的有效和敏感的检测方法,开发了与毛细管电泳联系的肝癌,多重甲基化特异性PCR(MSP)。结果模拟表明,即使DNA同时等于或超过12.5μg,也可以检测RASSF 1A,P16,SFRP1和ELF的甲基化状态。此外,其对甲基化检测的准确性超过了聚丙烯酰胺凝胶电泳(87.5%)和琼脂糖电泳(84.3%),达到92.1%。随后,我们利用毛细管电泳来研究多重MSP,以研究组织标本中的四个肿瘤抑制基因的甲基化状态,并探讨HCC患者的预后价值。随着数据的表明,多元COX回归分析显示,46名患者的复发存活率与门静脉肿瘤血栓(PVTT)大致有关,P16甲基化和接收器操作特征(ROC)曲线证明了门静脉肿瘤的预测范围与P16高甲基化相结合的血栓(PVTT)比HCC患者的疾病复发在疾病复发方面比PVTT或P16高甲基化更敏感,这可以在临床应用中被证实为有价值的生物标志物。结论多重MSP与毛细管电泳相结合,具有监测早期肝癌和筛选HCC患者预后的临床应用的优异前景。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号